搜索临床试验以:Placebo Paclitaxel
总计57630个结果
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)主动,不招人
-
Guangdong Association of Clinical Trials尚未招聘
-
Novartis Pharmaceuticals完全的
-
Eli Lilly and Company完全的
-
University of Alabama at Birmingham终止
-
Shanghai Henlius Biotech主动,不招人一项随机、双盲、安慰剂对照的 III 期研究,旨在研究 HLX10 + 化疗(卡铂-纳米颗粒白蛋白结合 (Nab) 紫杉醇)一线治疗 IIIB/IIIC 或 IV 期非小细胞肺癌患者的疗效和安全性鳞状非小细胞肺癌中国, 火鸡, 美国, 乔治亚州, 波兰, 俄罗斯联邦, 乌克兰
-
Genentech, Inc.完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.暂停
-
Nanfang Hospital of Southern Medical University招聘中
-
Tianjin Medical University Cancer Institute and...招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘
-
Qilu Hospital of Shandong University招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Mayo ClinicNational Cancer Institute (NCI)撤销解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 | 预后性 IIIC 期乳腺癌 AJCC v8 | 解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 转移性三阴性乳腺癌 | 局部晚期乳腺癌
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI); National Comprehensive Cancer Network完全的
-
University of Texas Southwestern Medical CenterCelgene完全的
-
Emory UniversityNational Cancer Institute (NCI)主动,不招人
-
University of UlmB. Braun Melsungen AG完全的
-
IRCCS Azienda Ospedaliera Universitaria San Martino...未知
-
First Affiliated Hospital of Zhejiang UniversityHangzhou Dihua Biotechnology Co., LTD.招聘中
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的
-
Gruppo Oncologico Italiano di Ricerca Clinica完全的
-
BioNumerik Pharmaceuticals, Inc.Lantern Pharma Inc. became Sponsor of Tavocept (BNP7787) IND 051014 as of March 26, 2019.完全的